Here's how diabetic foot diseases and foot ulcers are caused, who is at risk, signs to watch and expert tips to prevent or ...

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...

Study DUS-AUBD-01 opens patient enrollment PRINCETON, N.J., Nov. 14, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage ...

An undefinable disease cause and unpredictable ... h Reported as a significant difference between treatment and placebo groups in days with ulcers or ulcer pain. i Mean number of new ulcers ...

In the past, H. pylori infection and the use of NSAIDs have dominated research into peptic ulcer disease and have shaped its diagnosis and treatment. Even though H. pylori infection can be ...

Researchers are trialling the use of cell therapy used in cancer treatment, in the hope it could offer a possible cure for those with the illness. | ITV National News ...

Soligenix (SNGX) has opened patient enrollment for its Phase 2 study evaluating SGX945 – dusquetide – in the treatment of ...

Although the chronic autoimmune disease affects thousands, little is known about it and a cure does not currently exist ...

CNW/ - Microbion Corporation today announced positive topline safety and efficacy results from its recently completed Phase 2 ...

People living with the disease have been given hope of lifelong relief by a new cell therapy which has had successful results ...

Philips announced the first U.S. treatment using its new laser device that combines two peripheral artery disease (PAD) procedures into one.